Carboplatin (CBDCA) plus alpha interferon in metastatic non-small cell lung cancer: A Hoosier Oncology Group Phase II trial

R. Mandanas, L. H. Einhorn, B. Wheeler, R. Ansari, T. Lutz, M. E. Miller

Research output: Contribution to journalArticle

7 Scopus citations

Fingerprint Dive into the research topics of 'Carboplatin (CBDCA) plus alpha interferon in metastatic non-small cell lung cancer: A Hoosier Oncology Group Phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences